Ube Industries, Santen Pharmaceutical To Co-develop Rho-kinase …
Medical News Today - Tokyo - On May 9, Ube Industries and Santen Pharmaceutical jointly announced that they have basically agreed to develop DE-104, a compound that inhibits the activity of Rho-kinase (ROCK). Through collaboration, the two companies aim to develop an …
